BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on a previously announced voluntary recall of the BD Alaris™ System. Three of the situations described in this recall, which BD announced on June 30, 2020, have been designated as Cl



Source link